W. L. Gore & Associates améliore le portefeuille d’endoprothèses GORE® VIABAHN® avec la pose d’un profil plus bas

Les améliorations apportées aux dispositifs de grand diamètre comprennent l’accessibilité par des gaines plus petites tout en permettant une meilleure visualisation grâce à l’ajout de marqueurs radio-opaques

25 ans d’innovation continue

PUTZBRUNN, Allemagne, 22 septembre 2021 /PRNewswire/ — Dans le cadre de ses efforts pour améliorer continuellement les solutions médicales pour les patients souffrant de maladies vasculaires complexes, W. L. Gore & Associates, Inc. (Gore) a annoncé le lancement dans la région EMEA de l’endoprothèse GORE® VIABAHN® à profil plus bas et à grand diamètre avec surface bioactive PROPATEN. Les améliorations apportées à ce dispositif s’appuient sur une endoprothèse leader sur le marché, qui est devenue un outil important pour le traitement des maladies vasculaires complexes. La conception innovante du dispositif VIABAHN® réduit le profil de pose des grandes endoprothèses de 9 à 13 mm de diamètre jusqu’à 3 CH, ce qui permet de les poser dans des gaines plus petites. Des gaines d’introduction plus petites ont permis de réduire le risque de complications liées à l’accès vasculaire chez certaines populations de patients.1 En outre, de nouveaux marqueurs radio-opaques, désormais présents sur les configurations de dispositifs de plus grand diamètre, améliorent la visualisation sous fluoroscopie, facilitant le positionnement et la pose du dispositif, ainsi qu’un placement précis et prévisible. « Outre les marqueurs radio-opaques qui facilitent le positionnement et le déploiement, le nouveau profil plus bas permet d’utiliser une gaine plus petite, ce qui réduit potentiellement le risque de dommages au niveau du site d’accès », a déclaré Manuel Alonso, docteur en médecine, chirurgien vasculaire, Oviedo, Espagne. « Associée à la traçabilité et à la flexibilité, cette nouvelle offre de profil plus bas deviendra très utile dans ma pratique pour traiter les patients complexes dans tous les états pathologiques. »

GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface

« L’histoire de l’endoprothèse GORE® VIABAHN® est l’histoire d’une collaboration entre médecins pour quatre indications centrées sur le patient et d’une performance prouvée à maintes reprises », a déclaré Benjamin Beckstead, responsable de la catégorie vasculaire chez Gore.

Depuis son lancement dans l’UE en 1996, le dispositif a évolué grâce à de nombreuses améliorations et a pris en charge des centaines de milliers de patients dans le monde entier. Actuellement, le dispositif VIABAHN® est utilisé dans de nombreuses indications cliniques telles que les lésions de l’artère fémorale superficielle (AFS), les lésions iliaques, la resténose intra-stent des lésions de l’AFS et les lésions du circuit d’accès artério-veineux (AV).*

Pour plus d’informations, rendez-vous sur le site https://www.goremedical.com/eu/products/viabahn

* Pour obtenir des indications complètes et d’autres informations importantes sur la sécurité des produits commerciaux Gore mentionnés dans le présent document, reportez-vous aux instructions d’utilisation.

1. Applegate RJ, Sacrinty MT, Kutcher MA, et al. Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007. JACC : Cardiovascular Interventions 2008;1(3):317-326.

W. L. Gore & Associates Logo

Gore conçoit des dispositifs médicaux qui traitent toute une série de maladies cardiovasculaires et d’autres problèmes de santé. Avec plus de 50 millions de dispositifs médicaux implantés pendant plus de 45 ans, Gore s’appuie sur sa réputation pour améliorer le pronostic des patients à travers la recherche, la formation et la démarche qualité. L’efficacité des produits, la facilité d’utilisation et la qualité du service permettent aux médecins, aux hôpitaux et aux assureurs de réaliser des économies significatives. Gore est au service des cliniciens et grâce à cette collaboration, nous améliorons des vies.

À propos de Gore

W. L. Gore & Associates est une entreprise internationale spécialisée dans la science des matériaux et dont l’objectif est l’amélioration du secteur et des conditions de vie. Depuis 1958, Gore répond à des défis techniques complexes dans des environnements exigeants – de l’espace aux plus hauts sommets du monde en passant par le fonctionnement interne du corps humain. Avec plus de 11 000 associés et une forte culture axée sur le travail en équipe, Gore génère un chiffre d’affaires annuel de $3,8 milliards de dollars.

gore.com

Les produits énumérés peuvent ne pas être disponibles sur tous les marchés.

GORE, together, improving life, PROPATEN et HELEX, et les modèles sont des marques déposées de W. L. Gore & Associates.

Photo – https://mma.prnewswire.com/media/1628622/GORE_VSX_LDPro_final_highres.jpg

Logo – https://mma.prnewswire.com/media/340166/W_L_Gore_and_Associates_Logo.jpg

W. L. Gore & Associates Enhances GORE® VIABAHN® Endoprosthesis Portfolio With Lower Profile Delivery

Improvements to large diameter devices include accessibility through smaller sheaths while providing enhanced visualization by adding radiopaque markers

25 years of continued innovation

PUTZBRUNN, Germany, Sept. 22, 2021 /PRNewswire/ — As part of efforts to continuously improve medical solutions for patients with complex vascular disease, W. L. Gore & Associates, Inc. (Gore) announced the EMEA launch of the lower profile, large diameter GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface. The device enhancements build on a market-leading stent graft device, which has become an important tool for treating complex vascular disease. The innovative VIABAHN® Device design reduces the delivery profile for larger 9–13 mm diameter stent grafts by up to 3 Fr, enabling delivery through smaller sheaths. Smaller introducer sheaths have resulted in a lower risk of vascular access complications in select patient populations.1 Additionally, new radiopaque markers, now also on the larger diameter device configurations, enhance visualization under fluoroscopy, facilitating positioning and device delivery, as well as precise and predictable placement. “In addition to the radiopaque markers that facilitate positioning and deployment, the new lower profile enables use of a smaller sheath, potentially reducing the risk of damage at the access site,” said Manuel Alonso, M.D., Vascular Surgeon, Oviedo, Spain. “Combined with the trackability and flexibility this new lower profile offering will become very instrumental for treating complex patients across disease states in my practice.”

GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface

“The story of the GORE® VIABAHN® Endoprosthesis is a story of physician collaboration across four patient-centric indications and of proving performance over and over,” said Benjamin Beckstead, Gore Vascular Category Leader.

Since its EU launch in 1996, the device has evolved with numerous enhancements and supported hundreds of thousands of patients worldwide. Currently, the VIABAHN® Device is used in various clinical indications such as in superficial femoral artery (SFA) lesions, iliac lesions, in-stent restenosis of SFA lesions and AV Access circuit lesions.*

For more information, visit https://www.goremedical.com/eu/products/viabahn

* For complete indications and other important safety information for Gore commercial products referenced herein, refer to the applicable Instructions for Use (IFU).

1. Applegate RJ, Sacrinty MT, Kutcher MA, et al. Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007. JACC: Cardiovascular Interventions 2008;1(3):317-326.

W. L. Gore & Associates Logo

Gore engineers medical devices that treat a range of cardiovascular and other health conditions. With more than 50 million medical devices implanted over the course of more than 45 years, Gore builds on its legacy of improving patient outcomes through research, education and quality initiatives. Product performance, ease of use and quality of service provide sustainable cost savings for physicians, hospitals and insurers. Gore is joined in service with clinicians and through this collaboration we are improving lives.

About Gore

W. L. Gore & Associates is a global materials science company dedicated to transforming industries and improving lives. Since 1958, Gore has solved complex technical challenges in demanding environments — from outer space to the world’s highest peaks to the inner workings of the human body. With more than 11,000 Associates and a strong, team-oriented culture, Gore generates annual revenues of $3.8 billion.

gore.com

Products listed may not be available in all markets.

GORE, Together, improving life, PROPATEN, VIABAHN and designs are trademarks of W. L. Gore & Associates.

Photo – https://mma.prnewswire.com/media/1628622/GORE_VSX_LDPro_final_highres.jpg

Logo – https://mma.prnewswire.com/media/340166/W_L_Gore_and_Associates_Logo.jpg

Russia, Zimbabwe sign MOU on cooperation in the field of peaceful use of atomic energy

VIENNA (Austria), Sept 22 (NNN-KBC) — Russia and Zimbabwe signed a Memorandum of Understanding on cooperation in the field of peaceful uses of atomic energy on the sidelines of the 65th IAEA General Conference in Vienna.

From the Russian side, the document was signed by Russian State Atomic Energy Corporation (ROSATOM) Director General Alexey Likhachev, while Minister of Energy and Power Development Soda Zhemu signed the document on behalf of Zimbabwe.

The Memorandum is the first document signed between the Russian Federation and the Republic of Zimbabwe in the field of peaceful uses of atomic energy.

The document creates a basis for cooperation in a wide range of areas such as projects in the sphere of non-power applications of atomic energy in industry, agriculture and medicine.

Particular attention is paid to personnel training for the Zimbabwean national atomic industry and raising public awareness of nuclear energy.

Rosatom is one of the global technological leaders, a diversified holding with energy, mechanical engineering, and construction assets. Rosatom is one of the ten largest companies in Russia.

Having competencies throughout the entire nuclear fuel cycle, Rosatom has the largest foreign project portfolio in the world; 35 power units at different stages of implementation in 12 countries, including several African countries: Zambia, Rwanda, Ghana, Kenya, Tanzania, Nigeria, Namibia and South Africa.

Rosatom develops Africa in different ways, not only NPP building but also constructing the Nuclear Science and Technology Centers, supporting ecological initiatives and providing food security.

Source: NAM NEWS NETWORK

China’s COVID-19 vaccine arrives in Denmark for UN Peacekeeping personnel

COPENHAGEN, Sept 22 (NNN-Xinhua) — A consignment of China’s Sinopharm COVID-19 vaccines arrived in Copenhagen as the Chinese government’s donation for United Nations Peacekeeping personnels.

The delivery ceremony of the donation was held virtually last Friday and those vaccines are expected to be distributed to front-line personnel and close partners through the UN system as soon as possible.

The Chinese donation will be used in the African mission area on a priority basis, said Zhang Maoyu, deputy head of the China International Development Cooperation Agency, at the delivery ceremony.

China’s donation will enhance the UN capacity to respond to the epidemic and help peacekeepers better fulfill their duties and missions, according to Christian Francis Saunders, UN’s Assistant Secretary-General for Supply Chain Management.

Source: NAM NEWS NETWORK

Brazil and Argentina tapped to make mRNA COVID-19 vaccines in Latin America

BRASILIA, Sept 22 (NNN-AGENCIES) — The Pan American Health Organization (PAHO) has selected two biomedical centres in Argentina and Brazil as regional hubs to develop and produce mRNA-based vaccines to fight COVID-19 in Latin America, the regional health agency said.

The idea is to tap existing manufacturing capacities to help transfer vaccine technology developed by Moderna in the United States to a region badly hit by the coronavirus and still without access to enough vaccines.

The Bio-Manguinhos Institute of Technology on Immunobiologicals at Fiocruz, Brazil’s premier biomedical lab, was picked for its history of vaccine manufacturing, and has already made “promising advances” developing mRNA vaccine technology, PAHO said.

Sinergium Biotech, a private sector biopharmaceutical company, was selected as the centre in Argentina and will partner with pharmaceutical lab mAbxience of the same group to develop and manufacture active vaccine ingredients.

The Americas branch of the World Health Organization said vaccine manufacture should benefit the entire region, with distribution funded by PAHO’s Revolving Fund.

A similar effort in Africa to develop COVID-19 vaccine production replicating Moderna’s shot has been slowed by talks with the US company, a WHO official said last week.

Moderna said in October it would not enforce patents related to its shot during the pandemic, raising hopes that other companies might be able to copy its vaccine and help boost global production.

In practice, though, it is hard to replicate a vaccine without the information on how it is made, and the WHO-backed tech transfer hub in South Africa has so far not reached a deal with the company.

The Americas region has borne the brunt of COVID-19 infections to date, with 87.6 million cases recorded and over 2.16 million lives lost. Yet vaccine distribution continues to be unequal, PAHO has said, with few countries in the region reaching the year-end 40 per cent vaccine target set by the WHO.

Source: NAM NEWS NETWORK

South Sudanese refugees homeless again after Sudan floods

AL-JABALAIN (Sudan), Sept 22 (NNN-AGENCIES) — South Sudanese refugee Dawood Kour fled to Sudan to turn the page on a life of displacement, only to be forced onto the streets once more after floodwaters submerged his rickety

shelter.

Kour crossed the border in November, fleeing years of conflict in his home city of Malakal — itself prone to flooding.

South Sudan became the world’s newest independent nation in 2011, seceding from Sudan. But in late 2013, it plunged into a devastating, five-year civil war that it has yet to fully recover from.

Since fleeing, Kour had lived in the Al-Qanaa camp, a growing community of around 35,000 refugees in the Al-Jabalain district of White Nile state.

But this month, Kour was displaced yet again as floodwaters inundated the camp. He moved to the nearest patch of dry land he could find — the roadside.

The waters rose so fast that “we had no time to collect our belongings,” Kour said. “We only carried our children.”

“We now have no food, medication or anything to fight the swarms of mosquitoes.”

Over 288,000 residents and refugees have been affected in Sudan where heavy rains and flash floods have hit 13 of the 18 states, according to the United Nations.

Humanitarian needs have swelled, and been exacerbated by the disaster in neighbouring South Sudan too, where the deluge has affected and displaced about 426,000 people, the UN said.

In Sudan, thousands of refugees were relocated to different camps, while others took shelter in villages that were spared, but many are now living on the streets.

“They have become homeless,” said Ibrahim Mohamed, a senior official at Sudan’s refugee commission.

“We are facing a serious challenge of finding new land to relocate them to.”

Torrential rains pummel Sudan annually between June and October.

The downpours often leave the country grappling with severe flooding that wrecks properties, infrastructure and crops.

Last year, Sudan declared a three-month state of emergency as flooding that the UN has called the country’s worst in a century left around 140 people dead and 900,000 affected.

So far this year, the floods have killed more than 80 people nationwide and damaged or destroyed around 35,000 homes, according to Sudanese authorities.

In the Al-Jabalain district, neither Sudanese villagers nor the refugees were prepared for the inundation.

“Villagers say they have not witnessed such floods in 40 years,” said Anwar Abushura, the head of Al-Qanaa camp.

Refugees desperately built a rudimentary dirt barrier to try to protect their shelters, Kour said.

“But the water arrived at such a fast pace, and the flood barrier collapsed within two days,” he said.

Many refugees had to make their way through the stagnant floodwater to salvage building materials and belongings from the collapsed shelters.

“We have no food or even rugs to sleep on,” said refugee David Bedi, 45, whose shelter was engulfed.

“We just want to build roofs over our children’s heads.”

Aid workers have warned of a looming outbreak of diseases among the doubly displaced refugees.

Al-Qanaa camp head Abushura said they were expecting a “medical disaster”.

Around 150 refugees from Al-Qanaa and the nearby Al-Alagaya camp, including children, were diagnosed with malaria on Monday, according to figures compiled by Sudan’s refugee commission.

Darquos Manuel, 32, said food had been spoilt, “mosquitoes are eating the children and the rains continue to pour down even as we live on the streets”. “There is little chance for survival under these conditions,” he said.

At Al-Alagaya camp, where many refugees were relocated, Nagwa James pointed to shelters that had buckled under the relentless torrents of water.

“We fear… we will get flooded the same way Al-Qanaa did,” the South Sudanese refugee said.

Conditions were already poor, “mosquitoes are everywhere and there are alot of infections”, she added.

Mohamed Ali Abuselib, head of the camp, said refugees had been moved from low-lying areas.

But most are in the open, he added, “and we are expecting more floods”.

Source: NAM NEWS NETWORK

Nigeria: Insurgency in the North East Killed 300,000 Children – Unicef

ABUJA, Sept 22 (NNN-ALLAFRICA) — The United Nations Children’s Fund (Unicef) has reported that more than 300,000 children have died and over one million pushed out of school in 12 years of an insurgency in Nigeria’s North East region.

New data from the agency on the condition of children in the states of Borno, Adamawa and Yobe since 2009, when Boko Haram fighters first struck in the region, show that 5,129 out-of-school children are battling mental illnesses as a result of the conflict.

Unicef said the deaths underlined the direct and indirect attacks on children.

“Children killed in crossfires, improvised explosive devices (IEDs), children used as suicide bombers, children killed by malnutrition, among others,” said Peter Hawkins, Unicef’s representative in Nigeria.

“The scars of conflict are real and enduring for children. Too many children in northeast Nigeria are falling victim to a conflict they did not start.

“Attacks against children must stop immediately. In the meantime, we are committed to working with our partners to provide psychosocial and other support to conflict-affected children so they can regain their childhood and restart their lives.”

Hawkins said that the EU-funded Support to Early Recovery and Resilience Project, implemented by Unicef, was aimed at improving the mental health of 5,129 out-of-school children in Borno state.

He also said that stress and violence had been linked to poor brain development, depression and poor self-esteem and children exposed to conflict and violence were at risk of long-term mental health and psychosocial issues.

The conflict-affected out-of-school children in Borno were receiving services, including mental health support in safe spaces to strengthen their well-being, resilience, literacy skills and self-reliance, he said.

The agency’s intervention had provided 15,552 children with vocational training, 1,610 with literacy and numeracy skills, and 5,194 were enrolled into integrated Qur’anic schools.

The spokesman for the Nigerian army, Gen Onyeala Nwachukwu, has expressed worries that terrorists loyal to the Islamic State West Africa Province (ISWAP) remained relentless in their campaign as they have embarked on mass recruitment of terrorists.

At the headquarters of the Theatre Command for Operation Hadin Kai of the Nigerian army in Maiduguri, Borno state capital, he said: “I would like to mention that ISWAP, very recently, has been depleted by the surrendering of their members, as well as a conflict between them.

“They have embarked on what I will call a massive recruitment drive and I consider it very important to engage the media to block this recruitment.”

He noted that Boko Haram insurgents have been surrendering.

He explained that the troops had succeeded in curtailing the jihadist groups after insurgents almost took over the three state capitals of Adamawa, Borno and Yobe.

Three years ago, Boko Haram was advancing towards Abucha. Today they have been boxed into the Timbuks (islands in the Lake Chad region).

Source: NAM NEWS NETWORK